Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 7:41 pm Sale | 2020-12-31 | 13G | GoHealth, Inc. GOCO | VIKING GLOBAL INVESTORS LP | 173,394 3.100% | -130,546 (-42.95%) | Filing History |
| 2021-02-12 7:38 pm Sale | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 29,993,708 21.900% | -8,412,899 (-21.90%) | Filing History |
| 2021-02-12 7:36 pm Sale | 2020-12-31 | 13G | Change Healthcare Inc. CHNG | VIKING GLOBAL INVESTORS LP | 0 0.000% | -7,852,973 (Position Closed) | Filing History |
| 2021-02-12 7:34 pm Sale | 2020-12-31 | 13G | Vertex, Inc. VERX | VIKING GLOBAL INVESTORS LP | 0 0.000% | -1,852,269 (Position Closed) | Filing History |
| 2021-02-12 7:31 pm Sale | 2020-12-31 | 13G | Chewy, Inc. CHWY | VIKING GLOBAL INVESTORS LP | 0 0.000% | -2,896,423 (Position Closed) | Filing History |
| 2021-02-12 7:29 pm Sale | 2020-12-31 | 13G | aTyr Pharma, Inc. LIFE | VIKING GLOBAL INVESTORS LP | 0 0.000% | -816,728 (Position Closed) | Filing History |
| 2021-02-12 7:27 pm Sale | 2020-12-31 | 13G | Canada Goose Holdings Inc. GOOS | VIKING GLOBAL INVESTORS LP | 0 0.000% | -3,033,186 (Position Closed) | Filing History |
| 2021-02-12 1:09 pm Purchase | 2020-12-31 | 13G | Adaptive Biotechnologies Corporation ADPT | VIKING GLOBAL INVESTORS LP | 16,382,663 5.800% | 16,382,663 (New Position) | Filing History |
| 2020-12-23 8:37 pm Unchanged | 2020-12-14 | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 0 (Unchanged) | Filing History |
| 2020-12-21 5:28 pm Purchase | 2020-12-14 | 13G | AbCellera Biologics Inc. ABCL | VIKING GLOBAL INVESTORS LP | 19,283,744 7.200% | 19,283,744 (New Position) | Filing History |
| 2020-12-21 5:27 pm Purchase | 2020-12-15 | 13G | 4D Molecular Therapeutics, Inc. FDMT | VIKING GLOBAL INVESTORS LP | 3,937,914 14.900% | 3,937,914 (New Position) | Filing History |
| 2020-10-05 5:04 pm Purchase | 2020-09-25 | 13G | PMV Pharmaceuticals, Inc. PMVP | VIKING GLOBAL INVESTORS LP | 2,641,840 6.100% | 2,641,840 (New Position) | Filing History |
| 2020-09-28 5:04 pm Purchase | 2020-09-18 | 13G | Athira Pharma, Inc. ATHA | VIKING GLOBAL INVESTORS LP | 2,120,653 6.900% | 2,120,653 (New Position) | Filing History |
| 2020-08-31 4:51 pm Purchase | 2020-08-21 | 13G | Inhibrx Biosciences, Inc. INBX | VIKING GLOBAL INVESTORS LP | 5,125,647 13.600% | 5,125,647 (New Position) | Filing History |
| 2020-08-10 08:59 am Purchase | 2020-07-29 | 13G | Nuance Communications, Inc. NUAN | VIKING GLOBAL INVESTORS LP | 14,347,016 5.100% | 14,347,016 (New Position) | Filing History |
| 2020-08-10 08:55 am Purchase | 2020-07-29 | 13G | Vertex, Inc. VERX | VIKING GLOBAL INVESTORS LP | 1,852,269 8.200% | 1,852,269 (New Position) | Filing History |
| 2020-07-27 4:17 pm Purchase | 2020-07-16 | 13G | GoHealth, Inc. GOCO | VIKING GLOBAL INVESTORS LP | 303,939 5.400% | 303,939 (New Position) | Filing History |